dAURK-4 是 Alisertib 的一种衍生物,是一种有效的选择性AURKA (Aurora A)降解剂。dAURK-4 具有抗癌作用。
生物活性 | dAURK-4, an Alisertib derivative, is a potent and selectiveAURKA (Aurora A)degrader. dAURK-4 has anticancer effects[1]. |
IC50& Target[1] | |
体外研究 (In Vitro) | dAURK-4 (125-1000 nM; 4-24 hours) shows degradation of AURKA in a dose-depended manner[1].
Cell Viability Assay[1] Cell Line: | MM.1S cells | Concentration: | 125 nM, 250 nM, 500 nM, 1000 nM | Incubation Time: | 4 hours or 24 hours | Result: | Inhibited the protein level of AURKA (Aurora A). |
|
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |